BUY Hikal Limited — Kunal Saraogi
byKunal SaraogiHorizon: NA (inferred Swing (≤2wk))21 Sept 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Sameer Hiremath has been appointed as the Chairman and Managing Director of Hikal Ltd.
BSE · Company Update·23 Sept · today
Hikal Ltd has commenced commercial production at its new cGMP facility in Panoli, marking its entry into the Personal Care segment.
BSE · Company Update·22 Sept · yesterday
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Hikal
- BUY — ICICI Securities9 Sept 2024 · ~1 year · target ₹420 · Target hit
- BUY — ICICI Securities15 May 2024 · ~1 year · target ₹365 · Target hit
More from Kunal Saraogi
- BUY Shilpa Medicare6 Nov 2026 · ~1 year · target ₹1,160 · Active
- BUY AstraZeneca Pharma India6 Nov 2026 · ~1 year · target ₹8,800 · Active
- BUY BSE6 Nov 2026 · ~1 year · target ₹3,950 · Active
- BUY KPIT Technologies6 Nov 2026 · ~2 weeks · target ₹600 · Active
- BUY The Jammu & Kashmir Bank5 Nov 2026 · ~1 year · target ₹170 · Active

